QQ客服 官方微博 反馈留言

	YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
	Kong, Jian; Kong, Fandong; Gao, Jun; Zhang, Qiangbo; Dong, Shuying; Gu, Fang; Ke, Shan; Pan, Bing; Shen, Qiang; Sun, Huichuan
刊名	MOLECULAR CANCER
	2014
卷号	13
关键词	YC-1 Sorafenib Hepatocellular carcinoma STAT3
DOI	10.1186/1476-4598-13-7
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4794269
专题	山东大学
作者单位	Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing
推荐引用方式 GB/T 7714	Kong, Jian,Kong, Fandong,Gao, Jun,et al. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma[J]. MOLECULAR CANCER,2014,13.
APA	Kong, Jian.,Kong, Fandong.,Gao, Jun.,Zhang, Qiangbo.,Dong, Shuying.,...&Zhe 更多.(2014).YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.MOLECULAR CANCER,13.
MLA	Kong, Jian,et al."YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma".MOLECULAR CANCER 13(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。